Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate

Vaccine

Volumn 29, Issue 33, 2011, Pages 5567-5573

  Grund, Christian ^a   Abdelwhab, El Sayed M ^a,b,c   Arafa, Abdel Satar ^c   Ziller, Mario ^a   Hassan, Mohamed K ^c   Aly, Mona M ^c   Hafez, Hafez M ^b   Harder, Timm C ^a   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Agriculture Research Center   (Egypt)

Author keywords

Antigenic drift; Egypt; H5N1; Highly pathogenic avian influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; DRUG EFFICACY; DRUG POTENCY; EGYPT; IMMUNITY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; NONHUMAN; PHYLOGENY; POULTRY; PRIORITY JOURNAL; RNA SEQUENCE; VACCINATION; VIRUS STRAIN;

ANIMALS; CHICKENS; EGYPT; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY DISEASES; VACCINES, INACTIVATED; VIRUS SHEDDING;

EID: 79952194286     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.006     Document Type: Article

References (33)

1. Neumann G., Chen H., Gao G.F., Shu Y., Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties. Cell Res 2010, 20:51-61.
2. Cattoli G., Monne I., Fusaro A., Joannis T.M., Lombin L.H., Aly M.M., et al. Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS One 2009, 4:e4842.
3. Hulse-Post D.J., Sturm-Ramirez K.M., Humberd J., Seiler P., Govorkova E.A., Krauss S., et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 2005, 102:10682-10687.
4. Gambotto A., Barratt-Boyes S.M., de Jong M.D., Neumann G., Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008, 371:1464-1475.
5. Aly M.M., Arafa A., Hassan M.K. Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Dis 2008, 52:269-277.
6. Saad M.D., Ahmed L.S., Gamal-Eldein M.A., Fouda M.K., Khalil F., Yingst S.L., et al. Possible avian influenza (H5N1) from migratory bird, Egypt. Emerg Infect Dis 2007, 13:1120-1121.
7. Arafa A., Suarez D.L., Hassan M.K., Aly M.M. Phylogenetic analysis of HA and NA genes of HPAI-H5N1 Egyptian strains isolated from 2006 to 2008 indicates heterogeneity with multiple distinct sublineages. Avian Dis 2010, 54:345-349.
8. Abdel-Moneim A.S., Shany S.A., Fereidouni S.R., Eid B.T., el-Kady M.F., Starick E., et al. Sequence diversity of the haemagglutinin open reading frame of recent highly pathogenic avian influenza H5N1 isolates from Egypt. Arch Virol 2009, 154:1559-1562.
9. Fasina F.O., Ifende V.I., Ajibade A.A. Avian influenza A (H5N1) in humans: lessons from Egypt. Euro Surveill 2010, 15:19473.
10. Bouma A., Claassen I., Natih K., Klinkenberg D., Donnelly C.A., Koch G., et al. Estimation of transmission parameters of H5N1 avian influenza virus in chickens. PLoS Pathog 2009, 5:e1000281.
11. Kim J.K., Kayali G., Walker D., Forrest H.L., Ellebedy A.H., Griffin Y.S., et al. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proc Natl Acad Sci USA 2010, 107:11044-11049.
12. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
13. Escorcia M., Vázquez L., Méndez S.T., Rodríguez-Ropón A., Lucio E., Nava G.M. Avian influenza: genetic evolution under vaccination pressure. Virol J 2008, 5:15.
14. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
15. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008, 26(Suppl. 4):D31-34.
16. Lee C.W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004, 78:8372-8381.
17. Guan Y., Smith G.J., Webby R., Webster R.G. Molecular epidemiology of H5N1 avian influenza. Rev Sci Technol 2009, 28:39-47.
18. Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., et al. Avian influenza vaccination in Egypt: limitations of the current strategy. J Mol Genet Med 2009, 3:198-204.
19. Kaerber C. Kaerber's method of determining LD50. Biological standardization 1937, 37-40. Oxford University Press, London. J.H. Burn (Ed.).
20. Chen H., Bu Z. Development and application of avian influenza vaccines in China. Curr Top Microbiol Immunol 2009, 333:153-162.
21. Commission decision of 4 August 2006 approving a Diagnostic Manual for avian influenza as provided for in Council Directive 2005/94/EC (notified under document number C(2006) 3477) 26.(2006/437/EC).
22. Fereidouni S.R., Starick E., Beer M., Wilking H., Kalthoff D., Grund C., et al. Highly pathogenic avian influenza virus infection of mallards with homo- and heterosubtypic immunity induced by low pathogenic avian influenza viruses. PLoS One 2009, 4:e6706.
23. Starick E., Beer M., Hoffmann B., Staubach C., Werner O., Globig A., et al. Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus. Vet Microbiol 2008, 128:243-252.
24. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004, 32:1792-1797.
25. Milne I., Lindner D., Bayer M., Husmeier D., McGuire G., Marshall D.F., et al. TOPALi v2: a rich graphical interface for evolutionary analyses of multiple alignments on HPC clusters and multi-core desktops. Bioinformatics 2009, 25:126-127.
26. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008, ISBN 3-900051-07-0, URL: http://www.r-project.org/.
27. WHO/OIE/FAO H5N1 Evolution Working Group Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. Influenza Other Respi Viruses 2009, 3:59-62.
28. Abdelwhab E.M., Hafez H., Aly M., Grund C., Harder T.C. Increasing prevalence of unique mutation patterns in H5N1 avian influenza virus HA and NA glycoproteins from human infections in Egypt. Sequencing 2010, 1-4.
29. Duvvuri V.R., Duvvuri B., Cuff W.R., Wu G.E., Wu J. Role of positive selection pressure on the evolution of H5N1 hemagglutinin. Genomics Proteomics Bioinform 2009, 7:47-56.
30. Terregino C., Toffan A., Cilloni F., Monne I., Bertoli E., et al. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests. Avian Pathol 2010, 39:215-222.
31. Porollo A., Meller J., Versatile Annotation and publication quality visualization of protein complexes using POLYVIEW-3D. BMC Bioinformatics 2007, 8:316.
32. Bates P.A., Kelley L.A., MacCallum R.M., Sternberg M.J.E. Enhancement of protein modelling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins: Struct Funct Genet 2001, 5(Suppl.):39-46.
33. Archetti I., Horsfall F.L. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J Exp Med 1950, 92:441-462.